- ►prsjournal.com [PDF] L Arias, N Planas, S Prades, JM Caminal, M … - British Medical Journal, 2008 - bjo.bmj.com Results: There were 17 eyes of 17 patients, and the mean age was 55.4 (SD 10.0)
years. At the 6-month follow-up, the mean visual acuity improved by 8.4 letters
(p = 0.04). Forty-one per cent of patients increased at least one line, and ... Cited by 16 - Related articles - All 5 versions
M Gharbiya, F Allievi, L Mazzeo, CB Gabrieli - American Journal of Ophthalmology, 2009 - Elsevier PURPOSE: To evaluate the short-term efficacy and safety of intravitreal
bevacizumab for the treatment of myopic choroidal neovascularization (CNV).
DESIGN: Prospective, non-randomized, interventional case series. METHODS: ... Cited by 9 - Related articles - All 26 versions
Y Ikuno, K Sayanagi, K Soga, M Sawa, M … - American Journal of Ophthalmology, 2009 - Elsevier IVB was performed one to six times during the first 12 months (mean, 2.4 ± 1.4
times). The size of the mCNV decreased and the BCVA improved significantly (P <
.01 for both comparisons). The BCVA improved more than three lines in 25 ... Cited by 10 - Related articles - All 26 versions
- ►prsjournal.com RM Silva, JM Ruiz-Moreno, J Nascimento, A … - Retina, 2008 - pdfs.journals.lww.com A significant reduction in ocular coherence tomography central thickness was
observed at 1, 3, and 6 months. No cases of severe visual acuity loss occurred,
and no systemic or ocular side effects were registered during the ... Cited by 13 - Related articles - All 5 versions
F Rensch, UH Spandau, F Schlichtenbrede, S … - Ophthalmic surgery, lasers & imaging: the official … - ncbi.nlm.nih.gov BACKGROUND AND OBJECTIVE: To evaluate the effect of intravitreal bevacizumab on
visual acuity in patients with myopic choroidal neovascularization. PATIENTS AND
METHODS: The retrospective case series study included 13 patients with ... Cited by 5 - Related articles - BL Direct - All 3 versions
JM Ruiz-Moreno, F Gomez-Ulla, JA Montero, S … - Eye, 2009 - phx1.medscape.com New antiangiogenic drugs have been made available to treat subfoveal CNV
secondary to high myopia, although there have not been too many reports yet.
[11-20] The purpose of this pilot study is to evaluate the outcome of ... Cited by 16 - Related articles - All 8 versions
LK Chang, RF Spaide, C Brue, KB Freund, JM … - Archives of Ophthalmology, 2008 - archopht.highwire.org You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Add to CiteULike Add to ... Cited by 11 - Related articles - All 4 versions
S Mandal, P Venkatesh, R Sampangi, S Garg - European journal of ophthalmology - ncbi.nlm.nih.gov PURPOSE: To evaluate the short-term efficacy and safety of intravitreal
bevacizumab in myopic choroidal neovascularization (mCNV). METHODS: In this
noncomparative, consecutive, interventional case series, 12 eyes of 11 ... Cited by 19 - Related articles - BL Direct - All 3 versions
K Ohno-Matsui, M Moriyama, K Hayashi, M … - Graefe's Archive for Clinical and Experimental …, 2006 - Springer Abstract Purpose: To describe highly myopic patients in which either the large
choroidal veins or arteries were occluded following PDT treatment. Methods:
Demographic features of two highly myopic pa- tients in which large ... Cited by 14 - Related articles - BL Direct - All 4 versions
